Mednax, Inc. (MD): Price and Financial Metrics
MD Price/Volume Stats
| Current price | $12.71 | 52-week high | $19.63 |
| Prev. close | $12.68 | 52-week low | $12.23 |
| Day low | $12.66 | Volume | 406,800 |
| Day high | $12.88 | Avg. volume | 597,442 |
| 50-day MA | $13.70 | Dividend yield | N/A |
| 200-day MA | $14.35 | Market Cap | 1.07B |
MD Stock Price Chart Interactive Chart >
MD POWR Grades
- MD scores best on the Value dimension, with a Value rank ahead of 89.19% of US stocks.
- The strongest trend for MD is in Stability, which has been heading up over the past 177 days.
- MD ranks lowest in Sentiment; there it ranks in the 2nd percentile.
MD Stock Summary
- MD's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 259.35 -- higher than 88.73% of US-listed equities with positive expected earnings growth.
- In terms of volatility of its share price, MD is more volatile than merely 11.82% of stocks we're observing.
- Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for MD comes in at 14.12% -- higher than that of 87.16% of stocks in our set.
- If you're looking for stocks that are quantitatively similar to PEDIATRIX MEDICAL GROUP INC, a group of peers worth examining would be PETQ, NR, HRT, SRT, and MMS.
- Visit MD's SEC page to see the company's official filings. To visit the company's web site, go to www.mednax.com.
MD Valuation Summary
- MD's price/sales ratio is 0.5; this is 73.68% lower than that of the median Healthcare stock.
- Over the past 243 months, MD's price/sales ratio has gone down 1.6.
Below are key valuation metrics over time for MD.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| MD | 2023-09-22 | 0.5 | 1.1 | 10.1 | 10.2 |
| MD | 2023-09-21 | 0.5 | 1.1 | 10.3 | 10.3 |
| MD | 2023-09-20 | 0.5 | 1.1 | 10.3 | 10.3 |
| MD | 2023-09-19 | 0.5 | 1.1 | 10.3 | 10.3 |
| MD | 2023-09-18 | 0.5 | 1.1 | 10.4 | 10.4 |
| MD | 2023-09-15 | 0.5 | 1.1 | 10.4 | 10.3 |
MD Growth Metrics
- Its 3 year revenue growth rate is now at -45.87%.
- The year over year revenue growth rate now stands at 6.19%.
- The 4 year net cashflow from operations growth rate now stands at -43.52%.
The table below shows MD's growth in key financial areas (numbers in millions of US dollars).
| Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
|---|---|---|---|
| 2022-12-31 | 1,972.021 | 166.941 | 66.335 |
| 2022-09-30 | 1,956.707 | 112.491 | 84.192 |
| 2022-06-30 | 1,959.741 | 90.263 | 84.259 |
| 2022-03-31 | 1,946.667 | 61.443 | 92.134 |
| 2021-12-31 | 1,911.191 | 76.737 | 130.964 |
| 2021-09-30 | 1,829.291 | 20.635 | 19.152 |
MD's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- MD has a Quality Grade of C, ranking ahead of 56.08% of graded US stocks.
- MD's asset turnover comes in at 0.609 -- ranking 45th of 81 Healthcare stocks.
- ENZ, TDOC, and LFMD are the stocks whose asset turnover ratios are most correlated with MD.
The table below shows MD's key quality metrics over time.
| Period | Asset Turnover | Gross Margin | ROIC |
|---|---|---|---|
| 2021-06-30 | 0.609 | 0.263 | 0.026 |
| 2021-03-31 | 0.580 | 0.262 | -0.296 |
| 2020-12-31 | 0.479 | 0.259 | -0.262 |
| 2020-09-30 | 0.712 | 0.243 | -0.226 |
| 2020-06-30 | 0.780 | 0.242 | -0.745 |
| 2020-03-31 | 0.763 | 0.244 | -0.454 |
MD Price Target
For more insight on analysts targets of MD, see our MD price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
| Average Price Target | $30.60 | Average Broker Recommendation | 2 (Hold) |
Mednax, Inc. (MD) Company Bio
MEDNAX Inc. provides neonatal, anesthesia, maternal-fetal, and other pediatric subspecialties physician services in the United States and Puerto Rico. The company was founded in 1979 and is based in Sunrise, Florida.
Latest MD News From Around the Web
Below are the latest news stories about PEDIATRIX MEDICAL GROUP INC that investors may wish to consider to help them evaluate MD as an investment opportunity.
Long Term Returns of Jeff Smith’s Activist TargetsIn this article, we discuss long-term returns of Jeff Smith’s activist targets. If you want to see more stocks in this selection, check out Long Term Returns of Jeff Smith’s 5 Activist Targets. Once dubbed as one of the most feared men in corporate America, Jeff Smith is one of the most respected personalities when it […] |
Pediatrix Medical Group, Inc.'s (NYSE:MD) Has Performed Well But Fundamentals Look Varied: Is There A Clear Direction For The Stock?Pediatrix Medical Group's (NYSE:MD) stock is up by 5.8% over the past three months. However, the company's financials... |
Pediatrix Medical Group Reports Second Quarter ResultsFORT LAUDERDALE, Fla., August 03, 2023--Pediatrix Medical Group Reports Second Quarter Results |
Pediatrix Medical Group 2023 Second Quarter Conference Call/Webcast Scheduled for Thursday, August 3, 2023FORT LAUDERDALE, Fla., July 18, 2023--Pediatrix Medical Group 2023 Second Quarter Conference Call/Webcast Scheduled for Thursday, August 3, 2023 |
Pediatrix Medical Group's (NYSE:MD) Returns Have Hit A WallFinding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key... |
MD Price Returns
| 1-mo | -9.02% |
| 3-mo | -8.82% |
| 6-mo | -13.95% |
| 1-year | -23.02% |
| 3-year | -21.93% |
| 5-year | -72.57% |
| YTD | -14.47% |
| 2022 | -45.39% |
| 2021 | 10.88% |
| 2020 | -11.69% |
| 2019 | -15.79% |
| 2018 | -38.25% |
Continue Researching MD
Here are a few links from around the web to help you further your research on Mednax Inc's stock as an investment opportunity:Mednax Inc (MD) Stock Price | Nasdaq
Mednax Inc (MD) Stock Quote, History and News - Yahoo Finance
Mednax Inc (MD) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...